221 related articles for article (PubMed ID: 16621578)
1. Design and synthesis of novel metalloproteinase inhibitors.
Nakatani S; Ikura M; Yamamoto S; Nishita Y; Itadani S; Habashita H; Sugiura T; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M
Bioorg Med Chem; 2006 Aug; 14(15):5402-22. PubMed ID: 16621578
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a new chemical lead for a matrix metalloproteinase inhibitor.
Ikura M; Nakatani S; Yamamoto S; Habashita H; Sugiura T; Takahashi K; Ogawa K; Ohno H; Nakai H; Toda M
Bioorg Med Chem; 2006 Jun; 14(12):4241-52. PubMed ID: 16481176
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of an orally active matrix metalloproteinase inhibitor.
Yamamoto S; Nakatani S; Ikura M; Sugiura T; Nishita Y; Itadani S; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M
Bioorg Med Chem; 2006 Sep; 14(18):6383-403. PubMed ID: 16765051
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
[TBL] [Abstract][Full Text] [Related]
5. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of BACE1 inhibitors containing a novel norstatine derivative (2R,3R)-3-amino-2-hydroxy-4-(phenylthio)butyric acid.
Ziora Z; Kasai S; Hidaka K; Nagamine A; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2007 Mar; 17(6):1629-33. PubMed ID: 17251016
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of highly selective MMP-13 inhibitors.
Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.
Wang Q; Chen M; Zhu H; Zhang J; Fang H; Wang B; Xu W
Bioorg Med Chem; 2008 May; 16(10):5473-81. PubMed ID: 18467109
[TBL] [Abstract][Full Text] [Related]
10. The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases.
Hu LY; Boxer PA; Kesten SR; Lei HJ; Wustrow DJ; Moreland DW; Zhang L; Ahn K; Ryder TR; Liu X; Rubin JR; Fahnoe K; Carroll RT; Dutta S; Fahnoe DC; Probert AW; Roof RL; Rafferty MF; Kostlan CR; Scholten JD; Hood M; Ren XD; Schielke GP; Su TZ; Taylor CP; Mistry A; McConnell P; Hasemann C; Ohren J
Bioorg Med Chem Lett; 2006 May; 16(9):2337-40. PubMed ID: 16143519
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
Bioorg Med Chem; 2008 Apr; 16(7):3839-47. PubMed ID: 18304821
[TBL] [Abstract][Full Text] [Related]
12. Linear and nonlinear QSAR study of N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives as matrix metalloproteinase inhibitors.
Fernández M; Caballero J; Tundidor-Camba A
Bioorg Med Chem; 2006 Jun; 14(12):4137-50. PubMed ID: 16504515
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.
Mou J; Fang H; Liu Y; Shang L; Wang Q; Zhang L; Xu W
Bioorg Med Chem; 2010 Jan; 18(2):887-95. PubMed ID: 19969464
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.
Zhang YM; Fan X; Xiang B; Chakravarty D; Scannevin R; Burke S; Karnachi P; Rhodes K; Jackson P
Bioorg Med Chem Lett; 2006 Jun; 16(12):3096-100. PubMed ID: 16632358
[TBL] [Abstract][Full Text] [Related]
15. Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.
Szardenings AK; Harris D; Lam S; Shi L; Tien D; Wang Y; Patel DV; Navre M; Campbell DA
J Med Chem; 1998 Jun; 41(13):2194-200. PubMed ID: 9632351
[TBL] [Abstract][Full Text] [Related]
16. Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
Li Q; Fang H; Xu W
Bioorg Med Chem Lett; 2007 May; 17(10):2935-8. PubMed ID: 17433673
[TBL] [Abstract][Full Text] [Related]
17. A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.
Rossello A; Nuti E; Catalani MP; Carelli P; Orlandini E; Rapposelli S; Tuccinardi T; Atkinson SJ; Murphy G; Balsamo A
Bioorg Med Chem Lett; 2005 May; 15(9):2311-4. PubMed ID: 15837315
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD.
Strancar K; Blanot D; Gobec S
Bioorg Med Chem Lett; 2006 Jan; 16(2):343-8. PubMed ID: 16271472
[TBL] [Abstract][Full Text] [Related]
19. Rapid assembly of matrix metalloprotease inhibitors using click chemistry.
Wang J; Uttamchandani M; Li J; Hu M; Yao SQ
Org Lett; 2006 Aug; 8(17):3821-4. PubMed ID: 16898826
[TBL] [Abstract][Full Text] [Related]
20. Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme.
Humljan J; Kotnik M; Contreras-Martel C; Blanot D; Urleb U; Dessen A; Solmajer T; Gobec S
J Med Chem; 2008 Dec; 51(23):7486-94. PubMed ID: 19007109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
